美托洛尔缓释片治疗慢性心力衰竭患者的疗效观察-论文论文发表 关键词】 心力衰竭；心功能；再住院率；死亡率 [gap=882]Key words Heart failure，Heart function，Rehospitalization rate，mortality
基于28个网页-相关网页
BACKGROUND Cardiac resynchronization therapy(CRT),by pacing right and left ventricles,can improve symptoms and quality of life,reverse left ventricle remoding,reduce mortality and admission rate for heart failure patients with cardiac dyssynchrony.
背景心脏再同步治疗(CRT)作为充血性心力衰竭的一种新型非药物治疗方法,其改善心脏功能、逆转左心室重构、提高心衰患者生活质量、降低心衰再住院率及死亡率的临床疗效已经得到证实。
参考来源 - 充血性心力衰竭的心脏再同步治疗及术后参数优化·2,447,543篇论文数据，部分数据来源于NoteExpress
针对临床结果及再住院率，两份研究都无有力证据证实分享式决策效应。
There was no evidence of effect on clinical outcomes or hospital readmission rates in either study.
目的观察曲美他嗪治疗老年陈旧性心肌梗死合并慢性心力衰竭的疗效及对再住院率的影响。
Objective To observe the effects of trimetazidine on post-infarction chronic heart failure in aged patients and analyse the rate of rehospitalization.
结论：在常规抗心衰治疗基础上用卡维地洛片，可明显降低心率、改善心功能、降低再住院率。
Conclusion: the use of Carvedilol on the basis of routine CHF treatment may lower the heart rate, improve the heart function and decrease the rehospitalization rate.
应用推荐